SS-31 (also known as Elamipretide or MTP-131) is a cell-permeable tetrapeptide that specifically accumulates in the inner mitochondrial membrane, where it binds to cardiolipin — the unique phospholipid that is critical to mitochondrial architecture and function. SS-31 is arguably the most mechanistically precise anti-aging compound available: it targets the specific lipid that maintains mitochondrial cristae structure, and its application reverses the cristae collapse that underlies age-related mitochondrial dysfunction.

Cardiolipin: The Mitochondrial Structural Phospholipid

Cardiolipin is a phospholipid found almost exclusively in the inner mitochondrial membrane. It serves multiple critical functions: - Maintains the physical structure of cristae (the inner membrane folds that create surface area for the electron transport chain) - Anchors and stabilizes electron transport chain complexes I, III, IV, and V in their optimal positions - Facilitates proton gradient formation essential for ATP synthesis - Supports the assembly of the respiratory supercomplexes ("respirasomes")

In young, healthy mitochondria, cardiolipin is present in high concentrations and maintained in its reduced (non-oxidized) state. With aging, oxidative stress causes cardiolipin oxidation — and oxidized cardiolipin cannot perform these structural functions. The result is cristae collapse: the inner membrane loses its folded architecture, electron transport chain complexes dissociate, and ATP production efficiency falls dramatically.

This isn't a minor inefficiency. Aged muscle mitochondria can produce 50–70% less ATP per unit of substrate than young mitochondria — an age-related bioenergetic deficit that is a primary driver of sarcopenia, exercise intolerance, and metabolic decline.

How SS-31 Restores Function

SS-31 binds directly to cardiolipin through electrostatic interactions (its positively charged residues interact with cardiolipin's negative charge) and accumulates ~1000× more in inner mitochondrial membranes than cytoplasm. This targeting specificity is fundamental to its mechanism.

When bound to cardiolipin, SS-31: 1. Prevents cardiolipin oxidation: Acts as a targeted antioxidant at the inner membrane, scavenging reactive oxygen species generated by the electron transport chain before they can oxidize cardiolipin 2. Restores cristae structure: Protected cardiolipin maintains cristae architecture, restoring the physical geometry of the electron transport chain 3. Improves respiratory supercomplex assembly: Stabilized cardiolipin allows electron transport chain complexes to reassemble into higher-order supercomplexes, dramatically improving electron transfer efficiency 4. Increases ATP production: Downstream of all the above — functional cristae produce functional ATP synthesis

Clinical Development: Elamipretide

SS-31 is in clinical development as Elamipretide (brand name Bendavia) for multiple cardiovascular and mitochondrial disease indications: - Phase 2 for Heart Failure with Preserved Ejection Fraction (HFpEF): The SEET-HFpEF trial — initial data showed significant improvements in 6-minute walk distance and exercise tolerance - Phase 2 for Barth Syndrome: Rare mitochondrial cardiomyopathy — Phase 2 trial data showed improved cardiac function and exercise capacity - Phase 2 for Ischemia/Reperfusion: Studies showing protection of cardiac mitochondria during ischemic events

The clinical data provides human translational evidence for SS-31's mitochondrial improvement mechanism.

SS-31 and the Aging Mitochondria

Studies in aged mice and primate models have shown SS-31 can: - Reverse age-related skeletal muscle mitochondrial dysfunction in 8 weeks - Improve exercise capacity and VO2 max in aged animals - Restore mitochondrial cristae structure visible under electron microscopy - Reduce markers of mitochondrial oxidative stress These animal results have driven significant interest in SS-31 for human aging applications.